Guanjun Deng

Chinese Academy of Sciences

Papers

1

Total Citations

249

H-Index

1

About

Dr. Guanjun Deng is a pioneering researcher at the intersection of biomimetic nanotechnology and cancer theranostics, whose work is redefining how we diagnose and treat brain cancers. His primary research areas include aggregation-induced emission (AIE) nanomaterials, near-infrared-II fluorescence imaging, and glioma-targeted therapy. Dr. Deng’s most celebrated contribution is the development of natural-killer-cell-inspired nanorobots, which combine living cell membranes with AIE-active luminescent cores. This bioinspired design, published in 2020 and garnering over 249 citations, enables precise, fluorescence-guided visualization and treatment of gliomas—a notoriously difficult-to-treat brain tumor. By mimicking the tumor-homing behavior of natural killer cells, his nanorobots achieve enhanced blood-brain barrier penetration and targeted drug delivery, offering a powerful new weapon against aggressive cancers. His work bridges the gap between science fiction and clinical reality, drawing inspiration from the "Terminator" concept of cybernetic organisms. With a growing citation impact and a reputation for translating biological principles into functional nanomedicines, Dr. Deng is shaping the future of precision oncology and intelligent drug delivery systems.

Research Focus

Key Achievements

1
H-Index
1
Papers
249
Total Citations
249
Avg Citations/Paper
🏆 Most Cited Paper
Natural-Killer-Cell-Inspired Nanorobots with Aggregation-Induced Emission Characteristics for Near-Infrared-II Fluorescence-Guided Glioma Theranostics
249 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Chinese Academy of Sciences

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago